{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:28:03Z","timestamp":1781332083850,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vascn.2020.106933","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T20:56:41Z","timestamp":1603745801000},"page":"106933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Use of the ZDF rat to model dietary fat induced hypercoagulability is limited by progressive and fatal nephropathy"],"prefix":"10.1016","volume":"107","author":[{"given":"Michael K.","family":"Pugsley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjory B.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy E.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Katavolos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Y.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley T.","family":"Parish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert E.","family":"Schultze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vascn.2020.106933_bb0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic cost of diabetes in the US in 2017","volume":"41","author":"ADA (American Diabetes Association)","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vascn.2020.106933_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular risk factors and venous thromboembolism: A meta-analysis","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2020.106933_bb0015","article-title":"Experimental diabetes mellitus in different animal models","volume":"9051426","author":"Al-Awar","year":"2016","journal-title":"Journal of Diabetes Research"},{"key":"10.1016\/j.vascn.2020.106933_bb0020","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1160\/TH07-11-0682","article-title":"Metabolic syndrome, haemostasis and thrombosis","volume":"99","author":"Alessi","year":"2008","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.vascn.2020.106933_bb0025","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1182\/blood-2011-03-340422","article-title":"Elevated fibrinogen causes thrombosis","volume":"117","author":"Ari\u00ebns","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.vascn.2020.106933_bb0030","first-page":"420","article-title":"A multispecies enzyme-linked immunosorbent assay for von Willebrand's factor","volume":"119","author":"Benson","year":"1992","journal-title":"Journal of Laboratory Clinical Medicine"},{"key":"10.1016\/j.vascn.2020.106933_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/01.ATV.18.4.621","article-title":"Elevated plasma fibrinogen: Cause or consequence of cardiovascular disease?","volume":"18","author":"van der Bom","year":"1998","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"key":"10.1016\/j.vascn.2020.106933_bb0040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/vcp.12534","article-title":"Preanalytic processing of rat plasma influences thrombin generation and fibrinolysis assays","volume":"46","author":"Brooks","year":"2017","journal-title":"Veterinary Clinical Pathology"},{"key":"10.1016\/j.vascn.2020.106933_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169976","article-title":"Non-lethal endotoxin injection: A rat model of hypercoagulability","volume":"12","author":"Brooks","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2020.106933_bb0050","doi-asserted-by":"crossref","first-page":"F1123","DOI":"10.1152\/ajprenal.00247.2014","article-title":"Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats","volume":"307","author":"Castoldi","year":"2014","journal-title":"American Journal of Physiology - Renal Physiology"},{"key":"10.1016\/j.vascn.2020.106933_bb0055","series-title":"Diabetes report card 2017","author":"CDC","year":"2018"},{"key":"10.1016\/j.vascn.2020.106933_bb0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11011-017-0007-3","article-title":"Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI-1 and obesity on stroke","volume":"32","author":"Chen","year":"2017","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.vascn.2020.106933_bb0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0021-9150(99)00265-8","article-title":"Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats","volume":"148","author":"Corsetti","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vascn.2020.106933_bb0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/01926230490268756","article-title":"Best practices guideline: Toxicologic histopathology","volume":"32","author":"Crissman","year":"2004","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.vascn.2020.106933_bb0075","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1538-7836.2007.02362.x","article-title":"Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay","volume":"5","author":"Curnow","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.vascn.2020.106933_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1757-7241-21-29","article-title":"Thrombelastography (TEG\u00ae): Practical considerations on its clinical use in trauma resuscitation","volume":"21","author":"Da Luz","year":"2013","journal-title":"Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine"},{"key":"10.1016\/j.vascn.2020.106933_bb0085","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0026-0495(00)80049-9","article-title":"Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state","volume":"49","author":"Etgen","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.vascn.2020.106933_bb0090","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00125-008-0935-x","article-title":"LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat","volume":"51","author":"Figarola","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.vascn.2020.106933_bb0095","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/CIRCULATIONAHA.106.658948","article-title":"Increasing cardiovascular disease burden due to diabetes mellitus: The Framingham heart study","volume":"115","author":"Fox","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2020.106933_bb0100","series-title":"High fat diets for diet-induced obesity models: A brief review of the scientific literature- October 2008","author":"Gajda","year":"2009"},{"key":"10.1016\/j.vascn.2020.106933_bb0105","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/oby.2002.130","article-title":"Fat intake affects adiposity, comorbidity factors, and energy metabolism of Sprague-Dawley rats","volume":"10","author":"Ghibaudi","year":"2002","journal-title":"Obesity Research"},{"key":"10.1016\/j.vascn.2020.106933_bb0110","doi-asserted-by":"crossref","first-page":"F1606","DOI":"10.1152\/ajprenal.00063.2012","article-title":"Angiotensin-(1\u20137) attenuates diabetic nephropathy in Zucker diabetic fatty rats","volume":"302","author":"Giani","year":"2012","journal-title":"American Journal of Physiology - Renal Physiology"},{"key":"10.1016\/j.vascn.2020.106933_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000073575","article-title":"The calibrated automated thrombogram (CAT): A universal routine test for hyper- and hypocoagulability","volume":"32","author":"Hemker","year":"2002","journal-title":"Pathophysiology of Haemostasis and Thrombosis"},{"key":"10.1016\/j.vascn.2020.106933_bb0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1258\/la.2011.010165","article-title":"Appropriateness of the Zucker diabetic fatty rat as a model for diabetic microvascular late complications","volume":"46","author":"Hempe","year":"2012","journal-title":"Laboratory Animal"},{"key":"10.1016\/j.vascn.2020.106933_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12576-011-0184-5","article-title":"Leptin resistance does not induce hyperphagia in the rat","volume":"62","author":"Higuchi","year":"2012","journal-title":"Journal of Physiological Sciences"},{"key":"10.1016\/j.vascn.2020.106933_bb0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ki.1988.51","article-title":"Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats","volume":"33","author":"Kasiske","year":"1988","journal-title":"Kidney International"},{"key":"10.1016\/j.vascn.2020.106933_bb0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ilar.32.3.4","article-title":"Zucker (fa\/fa) Rat","volume":"32","author":"Kava","year":"1990","journal-title":"ILAR Journal"},{"key":"10.1016\/j.vascn.2020.106933_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ilar.32.3.9","article-title":"Wistar diabetic fatty rat","volume":"32","author":"Kava","year":"1990","journal-title":"ILAR Journal"},{"key":"10.1016\/j.vascn.2020.106933_bb0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/IJNRD.S103784","article-title":"Rodent models of diabetic nephropathy: Their utilities and limitations","volume":"9","author":"Kitada","year":"2016","journal-title":"International Journal of Nephrology and Renovascular Disease"},{"key":"10.1016\/j.vascn.2020.106933_bb0150","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.amjcard.2009.10.048","article-title":"Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for continued health [REACH] registry)","volume":"105","author":"Krempf","year":"2010","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.vascn.2020.106933_bb0155","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1111\/j.1538-7836.2010.04047.x","article-title":"ISTH SSC workshop. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: Results of the international society on thrombosis and haemostasis SSC collaborative workshop","volume":"8","author":"Lacroix","year":"2010","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.vascn.2020.106933_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00949","article-title":"Implication of free fatty acids in thrombin generation and fibrinolysis in vascular inflammation in Zucker rats and evolution with aging","author":"Lagrange","year":"2017","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.vascn.2020.106933_bb0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00592-005-0197-8","article-title":"Insulin resistance in the Zucker diabetic fatty rat: A metabolic characterization of obese and lean phenotypes","volume":"42","author":"Leonard","year":"2005","journal-title":"Acta Diabetologica"},{"key":"10.1016\/j.vascn.2020.106933_bb0170","series-title":"Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling","first-page":"278","article-title":"Robust tests for equality of variances","author":"Levene","year":"1960"},{"key":"10.1016\/j.vascn.2020.106933_bb0175","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/dmrr.874","article-title":"Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats","volume":"24","author":"Li","year":"2008","journal-title":"Diabetes and Metabolism Research Reviews"},{"key":"10.1016\/j.vascn.2020.106933_bb0180","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0272-6386(95)90112-4","article-title":"Tubulointerstitial lesions in young Zucker rats","volume":"25","author":"Magil","year":"1995","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.vascn.2020.106933_bb0185","first-page":"292","article-title":"Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: Role of hydronephrosis","volume":"293","author":"Marsh","year":"2007","journal-title":"American Journal of Physiology: Heart Circulatory Physiology"},{"key":"10.1016\/j.vascn.2020.106933_bb0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.vascn.2005.09.005","article-title":"Integrated in vivo pharmacology using an instrumented, unrestrained and conscious rat platform: Application to rat models of diabetes","volume":"53","author":"Nantel","year":"2006","journal-title":"Journal of Pharmacological & Toxicological Methods"},{"key":"10.1016\/j.vascn.2020.106933_bb0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.mbc.0000198047.35010.77","article-title":"Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation","volume":"17","author":"Nielsen","year":"2006","journal-title":"Blood, Coagulation and Fibrinolysis"},{"key":"10.1016\/j.vascn.2020.106933_bb0200","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I","volume":"34","author":"Paneni","year":"2013","journal-title":"European Heart Journal"},{"key":"10.1016\/j.vascn.2020.106933_bb0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bjp.0706957","article-title":"Increased platelet aggregation in vivo in the Zucker diabetic fatty rat: Differences from the streptozotocin diabetic rat","volume":"150","author":"Paul","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2020.106933_bb0210","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1002\/cptx.55","article-title":"Effects of rodent diet choice and fiber type on data interpretation of gut microbiome and metabolic disease research","volume":"77","author":"Pellizzon","year":"2018","journal-title":"Current Protocols in Toxicology"},{"key":"10.1016\/j.vascn.2020.106933_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/cdn\/nzaa031","article-title":"Choice of laboratory rodent diet may confound data interpretation and reproducibility","volume":"4","author":"Pellizzon","year":"2020","journal-title":"Current Developments in Nutrition"},{"key":"10.1016\/j.vascn.2020.106933_bb0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000025912","article-title":"Progression of diabetic nephropathy. Insights from cell culture studies and animal models","volume":"22","author":"Phillips","year":"1999","journal-title":"Kidney and Blood Pressure Research"},{"key":"10.1016\/j.vascn.2020.106933_bb0225","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.vascn.2020.106933_bb0230","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/oby.2011.18","article-title":"Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: Comparison to high-fat diet","volume":"19","author":"Sampey","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.vascn.2020.106933_bb0235","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0192623312460924","article-title":"Current practices in preclinical drug development: Gaps in hemostasis testing to assess risk of thromboembolic injury","volume":"41","author":"Schultze","year":"2013","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.vascn.2020.106933_bb0240","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.thromres.2014.04.008","article-title":"Zucker diabetic fatty rats exhibit hypercoagulability and accelerated thrombus formation in the arterio-venous shunt model of thrombosis","volume":"134","author":"Shang","year":"2014","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.vascn.2020.106933_bb0245","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"key":"10.1016\/j.vascn.2020.106933_bb0250","doi-asserted-by":"crossref","first-page":"E1730","DOI":"10.1152\/ajpendo.00572.2007","article-title":"Dynamics of insulin sensitivity, cell function, and cell mass during the development of diabetes in fa\/fa rats","volume":"293","author":"Topp","year":"2007","journal-title":"American Journal of Physiology, Endocrinology & Metabolism"},{"key":"10.1016\/j.vascn.2020.106933_bb0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1681\/ASN.V71113","article-title":"Evolution of metabolic and renal changes in the ZDF\/Drt-fa rat model of type II diabetes","volume":"7","author":"Vora","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.vascn.2020.106933_bb0260","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1573399810666140508121012","article-title":"Leptin- and leptin receptor-deficient rodent models: Relevance for human type 2 diabetes","volume":"10","author":"Wang","year":"2014","journal-title":"Current Diabetes Review"},{"key":"10.1016\/j.vascn.2020.106933_bb0265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cmet.2008.03.014","article-title":"Comparisons of diets used in animal models of high fat feeding","volume":"7","author":"Warden","year":"2008","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.vascn.2020.106933_bb0270","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.2460\/ajvr.1990.51.07.1080","article-title":"Chromogenic assay for equine plasminogen","volume":"51","author":"Welles","year":"1990","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.vascn.2020.106933_bb0275","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.physbeh.2010.04.006","article-title":"Decreased food intake following overfeeding involves leptin-dependent and leptin-independent mechanisms","volume":"100","author":"White","year":"2010","journal-title":"Physiology & Behavior"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871920302641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871920302641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:03:52Z","timestamp":1761005032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871920302641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":55,"alternative-id":["S1056871920302641"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2020.106933","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of the ZDF rat to model dietary fat induced hypercoagulability is limited by progressive and fatal nephropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2020.106933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106933"}}